摘要
目的评价医院心血管中成药的应用情况。方法对2004—2007年心血管中成药的种类、销售金额、用药频度等进行统计、分析。结果心血管中成药销售金额逐年上升,银杏、复方丹参制剂的用药金额和用药频度均排前列。结论心血管中成药应用基本合理,中药制剂应用前景广阔。
Objective To evaluate the current situation and the developmental trend of the application of Chinese patent cardiovascular medicines in our hospital. Methods The Chinese patent cardiovascular medicines used in our hospital during 2004-2007 were analyzed retrospectively and statistically in terms of drug varieties, consumption sum, DDDs, etc. Results The consumption sum of Chinese patent cardiovascular medicines was in an increasing tendency. The consumption sum and DDDs in the preparations of gingko and compound Salvia Mihiorrhiza was in the top positions. Conclusion Clinical application of Chinese patent cardiovascular medicines is basically rational in our hospital,and the prospect for the use of Chinese patent medicines is promising.
出处
《中国药业》
CAS
2009年第18期49-50,共2页
China Pharmaceuticals
基金
成都市药学会医院药学科研基金
项目编号:2008018